Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Comprehensive Assessment of Copy Number Alterations Uncovers Recurrent AIFM3 and DLK1 Copy Gain in Medullary Thyroid Carcinoma

Full text
Author(s):
Show less -
Araujo, Aline Neves [1] ; Camacho, Cleber Pinto [2] ; Mendes, Thais Biude [1] ; Lindsey, Susan Chow [2] ; Moraes, Lais [1] ; Miyazawa, Marta [1] ; Delcelo, Rosana [3] ; Pellegrino, Renata [4] ; Mazzotti, Diego Robles [5] ; Maciel, Rui Monteiro de Barros [2] ; Cerutti, Janete Maria [1]
Total Authors: 11
Affiliation:
[1] Univ Fed Sao Paulo, Genet Bases Thyroid Tumors Lab, Div Genet, Dept Morphol & Genet, Escola Paulista Med, Pedro de Toledo 669, 11 Andar, BR-04039032 Sao Paulo - Brazil
[2] Univ Fed Sao Paulo, Lab Mol & Translat Endocrinol, Div Endocrinol, Dept Med, Escola Paulista Medicina, Pedro de Toledo 669, 11 Andar, BR-04039032 Sao Paulo - Brazil
[3] Univ Fed Sao Paulo, Dept Pathol, Escola Paulista Med, Rua Botucatu 740, BR-04023900 Sao Paulo - Brazil
[4] Childrens Hosp Philadelphia, Ctr Appl Genom, Res Inst, 3401 Civ Ctr Blvd, Philadelphia, PA 19101 - USA
[5] Univ Penn, Dept Med, Div Sleep Med, Perelman Sch Med, Philadelphia, PA 19104 - USA
Total Affiliations: 5
Document type: Journal article
Source: CANCERS; v. 13, n. 2 JAN 2021.
Web of Science Citations: 0
Abstract

Simple Summary Medullary thyroid cancer (MTC) is often discovered in its advanced stage. Although a rare disease, advanced MTC cases have poor prognosis and the treatment is often palliative. Several studies have reported the existence of an association between copy number alterations (CNAs) burden and cancer progression. Moreover, the accumulation of broad CNAs, which contribute to intra-tumor heterogeneity, might be required for immune evasion. The identification of the recurrent CNAs associated with tumor phenotype aided in discovering new therapeutics options in several cancer types. To our knowledge, CNA is not well characterized in MTC. We analyzed recurrent focal CNAs on MTC. Our analysis provides a novel insight on MTC biology and may help in uncovering novel potential therapeutic targets. Medullary thyroid carcinoma (MTC) is a malignant tumor originating from thyroid C-cells that can occur either in sporadic (70-80%) or hereditary (20-30%) form. In this study we aimed to identify recurrent copy number alterations (CNA) that might be related to the pathogenesis or progression of MTC. We used Affymetrix SNP array 6.0 on MTC and paired-blood samples to identify CNA using PennCNV and Genotyping Console software. The algorithms identified recurrent copy number gains in chromosomes 15q, 10q, 14q and 22q in MTC, whereas 4q cumulated losses. Coding genes were identified within CNA regions. The quantitative PCR analysis performed in an independent series of MTCs (n = 51) confirmed focal recurrent copy number gains encompassing the DLK1 (14q32.2) and AIFM3 (22q11.21) genes. Immunohistochemistry confirmed AIFM3 and DLK1 expression in MTC cases, while no expression was found in normal thyroid tissues and few MTC samples were found with normal copy numbers. The functional relevance of CNA was also assessed by in silico analysis. CNA status correlated with protein expression (DLK1, p = 0.01), tumor size (DLK1, p = 0.04) and AJCC staging (AIFM3 p = 0.01 and DLK1 p = 0.05). These data provide a novel insight into MTC biology, and suggest a common CNA landscape, regardless of if it is sporadic or hereditary MTC. (AU)

FAPESP's process: 10/13833-2 - ABI3 and ABI3BP, characterization of in vitro interactions and investigation of the signaling pathway
Grantee:Lais Moraes de Godoy
Support type: Scholarships in Brazil - Master
FAPESP's process: 14/06570-6 - Comprehensive whole exome, paired-end RNA and genome sequencing: new insights into genetic bases of thyroid carcinoma in pediatric and adult ages and applications in clinical practice
Grantee:Janete Maria Cerutti
Support type: Research Projects - Thematic Grants
FAPESP's process: 17/06487-0 - Identification of the metabolic profile of cells with ectopic expression of PVALB and investigation of the molecular mechanism associated with its expression in Hürthle cell adenomas
Grantee:Thais Biude Mendes
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 12/02248-7 - Evaluation of the relation between tumor angiogenesis and lymphangiogenesis in medullary thyroid carcinomas
Grantee:Marta Miyazawa
Support type: Scholarships in Brazil - Post-Doctorate